Role of hepatic metabolism in the convulsant action of m-fluorotyrosine.
D000818:Animals; D001921:Brain; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D005461:Fluorine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D006498:Hepatectomy; D007267:Injections; D007274:Injections, Intraperitoneal; D008099:Liver / Q000378:metabolism*; D008297:Male; D051379:Mice; D011335:Proadifen / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D012640:Seizures / Q000139:chemically induced*; D012663:Semicarbazides / Q000008:administration & dosage / Q000494:pharmacology; D014443:Tyrosine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*
D000697:Central Nervous System Stimulants; D011725:Pyridines; D012663:Semicarbazides; D005461:Fluorine; D014443:Tyrosine; D011335:Proadifen